580 related articles for article (PubMed ID: 16491133)
1. The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine.
Müller N; Schwarz MJ; Dehning S; Douhe A; Cerovecki A; Goldstein-Müller B; Spellmann I; Hetzel G; Maino K; Kleindienst N; Möller HJ; Arolt V; Riedel M
Mol Psychiatry; 2006 Jul; 11(7):680-4. PubMed ID: 16491133
[TBL] [Abstract][Full Text] [Related]
2. Elevated macrophage migration inhibitory factor and decreased transforming growth factor-beta levels in major depression--no influence of celecoxib treatment.
Musil R; Schwarz MJ; Riedel M; Dehning S; Cerovecki A; Spellmann I; Arolt V; Müller N
J Affect Disord; 2011 Nov; 134(1-3):217-25. PubMed ID: 21684012
[TBL] [Abstract][Full Text] [Related]
3. Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial.
Akhondzadeh S; Jafari S; Raisi F; Nasehi AA; Ghoreishi A; Salehi B; Mohebbi-Rasa S; Raznahan M; Kamalipour A
Depress Anxiety; 2009; 26(7):607-11. PubMed ID: 19496103
[TBL] [Abstract][Full Text] [Related]
4. Celecoxib enhances the effect of reboxetine and fluoxetine on cortical noradrenaline and serotonin output in the rat.
Johansson D; Falk A; Marcus MM; Svensson TH
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):143-8. PubMed ID: 22691715
[TBL] [Abstract][Full Text] [Related]
5. Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study.
Abbasi SH; Hosseini F; Modabbernia A; Ashrafi M; Akhondzadeh S
J Affect Disord; 2012 Dec; 141(2-3):308-14. PubMed ID: 22516310
[TBL] [Abstract][Full Text] [Related]
6. Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia.
Müller N; Riedel M; Scheppach C; Brandstätter B; Sokullu S; Krampe K; Ulmschneider M; Engel RR; Möller HJ; Schwarz MJ
Am J Psychiatry; 2002 Jun; 159(6):1029-34. PubMed ID: 12042193
[TBL] [Abstract][Full Text] [Related]
7. Celecoxib: a new augmentation strategy for depressive mood episodes. A systematic review and meta-analysis of randomized placebo-controlled trials.
Faridhosseini F; Sadeghi R; Farid L; Pourgholami M
Hum Psychopharmacol; 2014 May; 29(3):216-23. PubMed ID: 24911574
[TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind, celecoxib- and placebo-controlled study of the effectiveness of CS-706 in acute postoperative dental pain.
Moberly JB; Xu J; Desjardins PJ; Daniels SE; Bandy DP; Lawson JE; Link AJ; Truitt KE
Clin Ther; 2007 Mar; 29(3):399-412. PubMed ID: 17577461
[TBL] [Abstract][Full Text] [Related]
9. Using non-steroidal anti-inflammatory drugs in the treatment of depression.
Davis A; Gilhooley M; Agius M
Psychiatr Danub; 2010 Nov; 22 Suppl 1():S49-52. PubMed ID: 21057403
[TBL] [Abstract][Full Text] [Related]
10. Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial.
Asadabadi M; Mohammadi MR; Ghanizadeh A; Modabbernia A; Ashrafi M; Hassanzadeh E; Forghani S; Akhondzadeh S
Psychopharmacology (Berl); 2013 Jan; 225(1):51-9. PubMed ID: 22782459
[TBL] [Abstract][Full Text] [Related]
11. Celecoxib treatment in an early stage of schizophrenia: results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment.
Müller N; Krause D; Dehning S; Musil R; Schennach-Wolff R; Obermeier M; Möller HJ; Klauss V; Schwarz MJ; Riedel M
Schizophr Res; 2010 Aug; 121(1-3):118-24. PubMed ID: 20570110
[TBL] [Abstract][Full Text] [Related]
12. Celecoxib for the prevention of colorectal adenomatous polyps.
Arber N; Eagle CJ; Spicak J; Rácz I; Dite P; Hajer J; Zavoral M; Lechuga MJ; Gerletti P; Tang J; Rosenstein RB; Macdonald K; Bhadra P; Fowler R; Wittes J; Zauber AG; Solomon SD; Levin B;
N Engl J Med; 2006 Aug; 355(9):885-95. PubMed ID: 16943401
[TBL] [Abstract][Full Text] [Related]
13. Celecoxib decreases prostaglandin E2 concentrations in nipple aspirate fluid from high risk postmenopausal women and women with breast cancer.
Sauter ER; Qin W; Schlatter L; Hewett JE; Flynn JT
BMC Cancer; 2006 Oct; 6():248. PubMed ID: 17049084
[TBL] [Abstract][Full Text] [Related]
14. A prospective, randomized, double-blind, multicenter comparative study on the safety and efficacy of Celecoxib and GCSB-5, dried extracts of six herbs, for the treatment of osteoarthritis of knee joint.
Park YG; Ha CW; Han CD; Bin SI; Kim HC; Jung YB; Lim HC
J Ethnopharmacol; 2013 Oct; 149(3):816-24. PubMed ID: 23954277
[TBL] [Abstract][Full Text] [Related]
15. The antidepressant efficacy of reboxetine in patients with severe depression.
Montgomery S; Ferguson JM; Schwartz GE
J Clin Psychopharmacol; 2003 Feb; 23(1):45-50. PubMed ID: 12544375
[TBL] [Abstract][Full Text] [Related]
16. First-dose analgesic effect of the cyclo-oxygenase-2 selective inhibitor lumiracoxib in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled comparison with celecoxib [NCT00267215].
Wittenberg RH; Schell E; Krehan G; Maeumbaed R; Runge H; Schlüter P; Fashola TO; Thurston HJ; Burger KJ; Trechsel U
Arthritis Res Ther; 2006; 8(2):R35. PubMed ID: 16469112
[TBL] [Abstract][Full Text] [Related]
17. A prospective randomised multicentre study comparing continuous and intermittent treatment with celecoxib in patients with osteoarthritis of the knee or hip.
Luyten FP; Geusens P; Malaise M; De Clerck L; Westhovens R; Raeman F; Vander Mijnsbrugge D; Mathy L; Hauzeur JP; De Keyser F; Van den Bosch F
Ann Rheum Dis; 2007 Jan; 66(1):99-106. PubMed ID: 16815864
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of reboxetine compared with imipramine in a double-blind study in patients suffering from major depressive offsodes.
Berzewski H; Van Moffaert M; Gagiano CA
Eur Neuropsychopharmacol; 1997 Apr; 7 Suppl 1():S37-47; discussion S71-3. PubMed ID: 9169309
[TBL] [Abstract][Full Text] [Related]
19. The use of etoricoxib and celecoxib for pain prevention after periodontal surgery: a double-masked, parallel-group, placebo-controlled, randomized clinical trial.
Steffens JP; Santos FA; Pilatti GL
J Periodontol; 2011 Sep; 82(9):1238-44. PubMed ID: 21235334
[TBL] [Abstract][Full Text] [Related]
20. Reboxetine: a double-blind comparison with fluoxetine in major depressive disorder.
Massana J; Möller HJ; Burrows GD; Montenegro RM
Int Clin Psychopharmacol; 1999 Mar; 14(2):73-80. PubMed ID: 10220121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
